Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.98 USD | -1.54% | -8.83% | -20.11% |
13/05 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
13/05 | Transcript : Theravance Biopharma, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.11% | 44Cr | |
+37.74% | 72TCr | |
+33.95% | 59TCr | |
-2.07% | 37TCr | |
+20.25% | 33TCr | |
+2.99% | 28TCr | |
+16.57% | 24TCr | |
+9.83% | 21TCr | |
-4.46% | 21TCr | |
+7.43% | 17TCr |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Theravance Biopharma Rises After SVB Securities Initiates Outperform Rating